(Q40912246)

24 September 2017

Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line (English)

1 reference

24 September 2017

0 references

Ma L

1

1 reference

24 September 2017

Gauvillé C

2

1 reference

24 September 2017

Berthois Y

3

1 reference

24 September 2017

Millot G

4

1 reference

24 September 2017

Johnson GR

5

1 reference

24 September 2017

Calvo F

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

24 September 2017

1 reference

24 September 2017

18

1 reference

24 September 2017

47

1 reference

24 September 2017

6513-6520

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203042

24 September 2017

0 references

cites work

Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Single-steep transformation of human breast epithelial cells by SV40 large T oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Growth factor synthesis and human breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Recent status of the antisense oligonucleotide approaches in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Structure and function of human amphiregulin: a member of the epidermal growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Differential effects of EGF and amphiregulin on adhesion molecule expression and migration of colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

COOH-terminal extended recombinant amphiregulin with bioactivity comparable with naturally derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Loss of chromosome 3p arm differentiating tumorigenic from non-tumorigenic cells derived from the same SV40-transformed human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Characterization of a novel amphiregulin-related molecule in 12-O-tetradecanoylphorbol-13-acetate-treated breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203042

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203042

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference